Munis A
Viruses. 2020; 12(10).
PMID: 33003635
PMC: 7599719.
DOI: 10.3390/v12101106.
Cavalieri V, Baiamonte E, Lo Iacono M
Viruses. 2018; 10(6).
PMID: 29890733
PMC: 6024700.
DOI: 10.3390/v10060316.
Duan L, Du J, Liu X
Protein Sci. 2015; 24(10):1549-59.
PMID: 26174372
PMC: 4594655.
DOI: 10.1002/pro.2750.
Chen Z, Telfier P, Gettie A, Reed P, Zhang L, Ho D
J Virol. 1996; 70(6):3617-27.
PMID: 8648696
PMC: 190237.
DOI: 10.1128/JVI.70.6.3617-3627.1996.
Levy J
Microbiol Rev. 1993; 57(1):183-289.
PMID: 8464405
PMC: 372905.
DOI: 10.1128/mr.57.1.183-289.1993.
Equine infectious anemia.
Sellon D
Vet Clin North Am Equine Pract. 1993; 9(2):321-36.
PMID: 8395326
PMC: 7126748.
DOI: 10.1016/s0749-0739(17)30399-1.
The immunopathogenesis of equine infectious anemia virus.
Sellon D, Fuller F, McGuire T
Virus Res. 1994; 32(2):111-38.
PMID: 8067050
PMC: 7134051.
DOI: 10.1016/0168-1702(94)90038-8.
Hemagglutination of several strains of equine infectious anemia virus.
Sentsui H, Kono Y
Arch Virol. 1981; 67(1):75-84.
PMID: 6263225
DOI: 10.1007/BF01314604.
Isolation and comparative biochemical properties of the major internal polypeptides of equine infectious anemia virus.
Montelaro R, Lohrey N, Parekh B, Blakeney E, Issel C
J Virol. 1982; 42(3):1029-38.
PMID: 6178843
PMC: 256936.
DOI: 10.1128/JVI.42.3.1029-1038.1982.
Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins.
Henderson L, Sowder R, Smythers G, Oroszlan S
J Virol. 1987; 61(4):1116-24.
PMID: 3029406
PMC: 254072.
DOI: 10.1128/JVI.61.4.1116-1124.1987.
Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection.
Salinovich O, Payne S, Montelaro R, Hussain K, Issel C, Schnorr K
J Virol. 1986; 57(1):71-80.
PMID: 3001367
PMC: 252700.
DOI: 10.1128/JVI.57.1.71-80.1986.
Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection.
Perryman L, ORourke K, McGuire T
J Virol. 1988; 62(8):3073-6.
PMID: 2839723
PMC: 253753.
DOI: 10.1128/JVI.62.8.3073-3076.1988.
Antigenic variation of equine infectious anemia virus as detected by virus neutralization. Brief report.
Kono Y
Arch Virol. 1988; 98(1-2):91-7.
PMID: 2829799
DOI: 10.1007/BF01321009.
Change in host cell tropism associated with in vitro replication of equine infectious anemia virus.
Carpenter S, Chesebro B
J Virol. 1989; 63(6):2492-6.
PMID: 2470916
PMC: 250709.
DOI: 10.1128/JVI.63.6.2492-2496.1989.
Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24.
Casey J, Kim Y, Andersen P, Watson K, Fox J, Devare S
J Virol. 1985; 55(2):417-23.
PMID: 2410630
PMC: 254949.
DOI: 10.1128/JVI.55.2.417-423.1985.
Equine infectious anemia virus derived from a molecular clone persistently infects horses.
Whetter L, Archambault D, Perry S, Gazit A, COGGINS L, Yaniv A
J Virol. 1990; 64(12):5750-6.
PMID: 2173767
PMC: 248720.
DOI: 10.1128/JVI.64.12.5750-5756.1990.
Lentiviruses are etiological agents of chronic diseases in animals and acquired immunodeficiency syndrome in humans.
Narayan O
Can J Vet Res. 1990; 54(1):42-8.
PMID: 2155049
PMC: 1255605.
The topoisomerase I inhibitor, camptothecin, inhibits equine infectious anemia virus replication in chronically infected CF2Th cells.
Priel E, Showalter S, Roberts M, Oroszlan S, Blair D
J Virol. 1991; 65(8):4137-41.
PMID: 1649321
PMC: 248847.
DOI: 10.1128/JVI.65.8.4137-4141.1991.
The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro.
Perry S, Flaherty M, Kelley M, Clabough D, Tronick S, COGGINS L
J Virol. 1992; 66(7):4085-97.
PMID: 1318398
PMC: 241211.
DOI: 10.1128/JVI.66.7.4085-4097.1992.
Characterization of the infection of equine fibroblasts by equine infectious anemia virus.
Cheevers W, Crawford T
Arch Virol. 1979; 60(3-4):279-89.
PMID: 228638
DOI: 10.1007/BF01317499.